IC Class medications in patients with atrial fibrillation, arterial hypertension, chronic heart failure and intact systolic function

The study assessed clinical effectiveness and safety of propanorm in patients with arterial hypertension, chronic heart failure (CHF) without left ventricular systolic dysfunction, complicated with recurrent paroxysmal or persistent atrial AA fibrillation (AF). It was demonstrated that propanorm was effective and safe and could be combined with beta-adrenoblockers. In 29,3% of the participants, tachyarrhythmia terminated; in another 70,7% AF episode frequency reduced by 75,5%, and total time of AF episodes decreased by 81, 1%.